AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
4min chapter
Rerun: Lars Fruergaard Jørgensen CEO of Novo Nordisk
In Good Company with Nicolai Tangen
Intro
Exploring the global increase in obesity, this chapter focuses on Novo Nordisk's role in weight reduction medications and highlights the complexity of obesity as a disease influenced by lifestyle, genetics, diet, and demographics.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode